Phone: (414) 918-9822    Email: [email protected]

CARRA-Arthritis Foundation Large Grants

 

CARRA-Arthritis Foundation Large Grant Applications to Include:

  • Letter of Intent (LOI) (due September 1)
  • Project Summary/Abstract (300 word max)
  • Lay Summary (150 word max)
  • Resubmission Modifications, if applicable (1 page limit) (Download template: WORD)
  • Specific Aims (1 page limit) (Download template: WORD)
  • Research Plan (5 page limit) (Download template: WORD)
  • References (no page limit) (Download template: WORD)
  • Budget Table (1 page limit) (Download template: WORD)
  • Budget Justification (Download template: WORD)
    • Total costs of salary support for PI(s) and Co-I(s) must not exceed 50% of total project costs.
    • CARRA will allow up to 8% F&A (indirect) costs which must be incorporated into the project budget below. If indirect costs are requested, total costs for this project must not exceed $50,000.
    • Poster printing and publication costs are not allowed.
    • Travel expense requests are not permitted unless required for the conduct of research. Travel expenses to attend meetings to present this work, for example, are not allowed.
    • Other expenses should be discussed with CARRA personnel prior to application submission.
  • NIH-formatted biosketches for Principal Investigator(s) and Co-Investigator(s) (5 page limit per biosketch; please combine all biosketches into one PDF with the PI biosketch listed first.)
  • Letters of support
    • Required for budgets that include investigator effort (include letter from division chief documenting that % effort is available, and confirming investigator salary). Total costs salary support must not exceed 50% of total project costs.
    • Letters of support from collaborators, mentors and institution are highly recommended.
  • Research Assurances
  • Appendix (limit 1 attachment)

Please review the detailed application instructions prior to submission.  Use the templates provided when you submit your final application.

APPLICATIONS NOT FOLLOWING THESE GUIDELINES WILL NOT BE CONSIDERED


Now Accepting Applications


Important information for Large Grant Submissions

Letter of Intent due: September 1 / Complete Applications due: October 1

This funding opportunity supports the development and publication of a clinical or translational project which will immediately impact research projects within CARRA or result in a larger collaborative grant that furthers the CARRA mission. New or early investigators are encouraged to apply and will be afforded special consideration.  A successful application may be for:

  • an all-inclusive clinical or translational research project; or
  • a pilot research project, that if successful, could lead to extramural funding.

Preference will be given to submissions which are collaborative and leverage current CARRA network resources or will further develop the CARRA network.

Details:

  • A maximum of 2 grants will be awarded per year.
  • The funding maximum limit is $50,000 total costs.
  • Salary/Effort: Letters of support are required for budgets that include investigator effort (include letter from division chief documenting that % effort is available, and confirming investigator salary). Total costs salary support for the Principal Investigator(s) and Co-Investigator(s) must not exceed 50% of total project costs.
  • This is a total costs award. If indirects are requested, they must be inclusive of the maximum funding amount of $50,000. Indirects may not exceed 8%.
  • A given investigator can only receive one large or small grant per 365 day period.
  • Funds will be provided to the awardee’s institution as a lump sum to be set up in a sundry account and used by the principal investigator according to the project budget.
  • The project period is one year beginning April 1.
  • A project report is required no later than 45 days after the project period end date.
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting(s) until the project is complete/final.
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • After funding decisions are determined, one large grant will be selected by CARRA to be sponsored by funding received from AOII.

Instructions:

  • Submit a one-page Letter of Intent (LOI) on institution letterhead by September 1 via the online grant submission system.  
  • Read the CARRA-Arthritis Large Grant instructions carefully (coming soon). Be sure to be compliant with formatting instructions and page limits.
  • Use the document templates provided above and submit your completed CARRA-Arthritis Foundation Large Grant application by October 1 via the online grant submission system.

Letter of Intent (LOI) - Due September 1

LOI’s are required for those submitting Large Grants and are due 30 days prior (September 1) to the application deadline (October 1). The LOI should be a one-page signed letter which includes:

  • A summary of the full proposal with a short description of aims of the project involved.
  • Name of the PI(s) and submitting institution
  • A list of key personnel and role(s)
  • A description of how the project aligns with CARRA's mission.

The LOI MUST be on institutional letterhead and signed by the Principal Investigator(s).

While the LOI is an administrative requirement, it is for informational purposes only. Approval from CARRA is not needed to proceed with the full application. Investigators will receive confirmation that their LOI has been received by the CARRA grants office.

Eligibility

  • The project PI must be a current CARRA member who is up to date on both membership dues and membership information (location, contact information, and membership status).
  • An investigator may only receive one CARRA grant (large or small) per year (365 day period). 
  • MD applicants must be at faculty level.
  • PhD and Masters level researchers, nurses and research coordinators are eligible to submit proposals.
  • Priority will be given to new and/or early investigators.
  • All grants must be submitted by or have a pediatric rheumatologist named as a Co-I.
  • Fellows, residents, and CARRA Executive Committee members are not eligible.

Funding and Funding Period

  • Awards are total costs. Up to 8% F&A (indirect) costs are allowed, but costs must be incorporated into the project budget and not exceed the advertised award amount.
  • Publication, presentation, and travel costs should not be requested/included, unless the travel is an essential part of performing the research. Other expenses should be discussed with CARRA personnel prior to application submission.
  • Salary support will be limited to a base-salary cap of $200,000 but can include payment of local fringe rates (on top of $200,000 salary cap).
  • Please review CARRA’s statement of direct and indirect support.
  • After funding decisions are determined, one large grant will be selected by CARRA to be sponsored by funding received from AOII.
  • All awards are for one year, with funding beginning April 1.
  • Applicants will be notified of funding decisions in March 2019.
  • If the project is not completed within the project period, the award recipient may request a no-cost extension (NCE) for up to 12 months. Requests for NCEs can be made up to 90 days prior, but no less than 30 days prior, to the project end date. An interim progress report must be submitted with the NCE Request Form, both of which are available on the CARRA website.

Reporting

  • Awardees must submit a final progress report no later than 45 days after the project period end date.
  • Awardees from previous grant cycles who wish to submit grant applications for the October 2018 deadline must have all active projects completed and have submitted a final progress report (template available on the CARRA website).
  • Timely provision of progress reports is taken into consideration for future eligibility for CARRA-Arthritis Foundation grants.
  • Awardees are expected to submit abstracts to CARRA and present their findings at the CARRA Annual Scientific Meeting(s) until the project is complete/final.

Publications

  • Awardees are expected to submit a peer-reviewed abstract to a scientific meeting based on the funded project.
  • All awardees of CARRA-Arthritis Foundation funding must abide by the procedures outlined in the CARRA Publications Policy when presenting/publishing findings from their projects. This includes submitting all abstracts and manuscripts to the CARRA Publications Committee for approval prior to submission and acknowledging the support of CARRA and the Arthritis Foundation by including the following language: “The authors wish to acknowledge CARRA, and the ongoing Arthritis Foundation financial support of CARRA.” Refer to the current Publications Policy for complete details.